Your browser doesn't support javascript.
loading
Burkitt lymphoma with a granulomatous reaction: an M1/Th1-polarised microenvironment is associated with controlled growth and spontaneous regression.
Granai, Massimo; Lazzi, Stefano; Mancini, Virginia; Akarca, Ayse; Santi, Raffaella; Vergoni, Federica; Sorrentino, Ester; Guazzo, Raffaella; Mundo, Lucia; Cevenini, Gabriele; Tripodo, Claudio; Di Stefano, Gioia; Puccini, Benedetta; Ponzoni, Maurilio; Sabattini, Elena; Agostinelli, Claudio; Bassüllü, Nuray; Tecimer, Tülay; Demiroz, Ahu Senem; Mnango, Leah; Dirnhofer, Stephan; Quintanilla-Martinez, Leticia; Marafioti, Teresa; Fend, Falko; Leoncini, Lorenzo.
Afiliación
  • Granai M; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Lazzi S; Institute of Pathology, University of Tübingen, Tübingen, Germany.
  • Mancini V; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Akarca A; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Santi R; Department of Cellular Pathology, University College London, London, UK.
  • Vergoni F; Department of Pathology, University of Florence, Florence, Italy.
  • Sorrentino E; Department of Pathology, University of Florence, Florence, Italy.
  • Guazzo R; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Mundo L; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Cevenini G; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Tripodo C; Health Research Institute, University of Limerick, Limerick, Ireland.
  • Di Stefano G; Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Puccini B; Department of Human Pathology, University of Palermo, Palermo, Italy.
  • Ponzoni M; Department of Pathology, University of Florence, Florence, Italy.
  • Sabattini E; Department of Haematology, University of Florence, Florence, Italy.
  • Agostinelli C; Department of Pathology, University Vita-Salute San Raffaele, Milano, Italy.
  • Bassüllü N; Haemolymphopathology Unit - IRCCS - Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Tecimer T; Haemolymphopathology Unit - IRCCS - Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Demiroz AS; Department of Pathology, Bilim University, Istanbul, Turkey.
  • Mnango L; Department of Pathology, Acibadem University, Istanbul, Turkey.
  • Dirnhofer S; Department of Pathology, Istanbul University Cerrahpasa, Istanbul, Turkey.
  • Quintanilla-Martinez L; Department of Pathology, Muhimbili National Hospital and University for Healthcare and Allied Sciences, Dar-es-Salaam, Tanzania.
  • Marafioti T; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Fend F; Institute of Pathology, University of Tübingen, Tübingen, Germany.
  • Leoncini L; Department of Cellular Pathology, University College London, London, UK.
Histopathology ; 80(2): 430-442, 2022 Jan.
Article en En | MEDLINE | ID: mdl-33948980
AIMS: Burkitt lymphoma (BL) is an aggressive B-cell lymphoma that, in some instances, may show a granulomatous reaction associated with a favourable prognosis and occasional spontaneous regression. In the present study, we aimed to define the tumour microenvironment (TME) in four such cases, two of which regressed spontaneously. METHODS AND RESULTS: All cases showed aggregates of tumour cells with the typical morphology, molecular cytogenetics and immunophenotype of BL surrounded by a florid epithelioid granulomatous reaction. All four cases were Epstein-Barr virus (EBV)-positive with type I latency. Investigation of the TME showed similar features in all four cases. The analysis revealed a proinflammatory response triggered by Th1 lymphocytes and M1 polarised macrophages encircling the neoplastic cells with a peculiar topographic distribution. CONCLUSIONS: Our data provide an in-vivo picture of the role that specific immune cell subsets might play during the early phase of BL, which may be capable of maintaining the tumour in a self-limited state or inducing its regression. These novel results may provide insights into new potential therapeutic avenues in EBV-positive BL patients in the era of cellular immunotherapy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Células TH1 / Infecciones por Virus de Epstein-Barr / Microambiente Tumoral / Macrófagos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Histopathology Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Burkitt / Células TH1 / Infecciones por Virus de Epstein-Barr / Microambiente Tumoral / Macrófagos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Histopathology Año: 2022 Tipo del documento: Article País de afiliación: Italia